EUVIMEDEUVIMED entdecken
Open Access

TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy

Chenchen Hu, Feiming Hu, Changjian Shao, Yuanli He, Liping Su, Daimei Shi, Lingying Yu, Yuanjie Sun, Jing Wang, Xiyang Zhang, Hongtao Duan, Junqi Zhang und 5 weitere

Cancer Communications · 2026

DOI: 10.34133/cancomm.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Chenchen Hu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Basic Medicine School, Air Force Medical University, Xi'an 710032, Shaanxi, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Tumor Microenvironment, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Young Talent Fund of the Association for Science and Technology in Shaanxi, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung cancer remains a major global health burden. RNA-binding proteins (RBPs) play crucial roles in post-transcriptional gene regulation, and their dysregulation is frequently implicated in tumorigenesis. The present study aimed to elucidate the molecular network governed by the highly expressed RBP TIMELESS in lung adenocarcinoma (LUAD) and determine its mechanistic role in LUAD progression.

Methods

The Cancer Genome Atlas-LUAD, Gene Expression Omnibus, and single-cell RNA sequencing datasets were analyzed to identify aberrantly expressed RBP genes. The RBP gene TIMELESS exhibited the most significant effect on LUAD cell death and was selected for further study. Photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation sequencing and RNA sequencing were employed to identify ferroptosis-related targets directly bound by TIMELESS. Molecular mechanisms underlying the TIMELESS-mediated regulation of ferroptosis in LUAD were investigated via immunoprecipitation–mass spectrometry, glutathione S -transferase pull-down, immunofluorescence–fluorescence in situ hybridization, RNA immunoprecipitation, poly(A)-tail, and RNA stability assays. In an orthotopic lung cancer mouse model treated with erastin (a ferroptosis inducer) and programmed cell death protein 1 (PD-1) blockade, the role of TIMELESS in therapeutic response was assessed via flow cytometry and multiplex immunofluorescence (mIF). Infiltrating immune cells in LUAD were analyzed by tissue microarrays (TMAs) via mIF.

Results

TIMELESS significantly affected LUAD cell proliferation and death, and TIMELESS knockdown significantly enriched RNA-binding and ferroptosis pathways. Transferrin (TF) was identified as a direct TIMELESS target governing ferroptosis. TIMELESS was revealed to bind Ccr4-Not transcription complex subunit 3 (CNOT3) to promote TF mRNA degradation. TIMELESS depletion combined with erastin and PD-1 blockade enhances efficacy, prolongs survival, increases T cell and M1 macrophage infiltration, and reduces M2 macrophage infiltration. Further, high TIMELESS expression was inversely correlated with ferroptosis marker 4-hydroxynonenal but positively correlated with programmed cell death ligand 1 (PD-L1), reduced T cell and M1 macrophage infiltration, and increased M2 macrophage infiltration.

Conclusions

TIMELESS recruits CNOT3 to accelerate TF mRNA degradation, thereby suppressing ferroptosis and promoting LUAD growth. These findings suggest that the TIMELESS/TF regulatory axis may be a promising therapeutic target for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisTumor MicroenvironmentLung NeoplasmsAdenocarcinoma of LungTransferrinImmune Checkpoint InhibitorsIntracellular Signaling Peptides and ProteinsHumansAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticCell ProliferationPiperazinesFemaleImmunotherapy

Substanzen

TransferrinImmune Checkpoint InhibitorsIntracellular Signaling Peptides and ProteinsPiperazines

Autor:innen und Institutionen

  • Department of Immunology, Basic Medicine School, Air Force Medical University, Xi'an 710032, Shaanxi, P. R. China.
  • Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi, P. R. China.
  • Military Medical Innovation Center, Air Force Medical University, Xi'an 710032, Shaanxi, P. R. China.

Förderung

  • the National Natural Science Foundation of China
  • the Young Talent Fund of the Association for Science and Technology in Shaanxi, China

Zitieren

APA

Hu, C., Hu, F., Shao, C., He, Y., Su, L., Shi, D., Yu, L., Sun, Y., Wang, J., Zhang, X., Duan, H., Zhang, J., Sun, Y., Jiang, D., Yan, X., Yang, S., & Yang, K. (2026). TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy. Cancer Communications. https://doi.org/10.34133/cancomm.0009

Vancouver

Hu C, Hu F, Shao C, He Y, Su L, Shi D, et al. TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy. Cancer Communications. 2026. doi:10.34133/cancomm.0009

BibTeX
@article{Hu2026,
  author = {Hu, Chenchen and Hu, Feiming and Shao, Changjian and He, Yuanli and Su, Liping and Shi, Daimei and Yu, Lingying and Sun, Yuanjie and Wang, Jing and Zhang, Xiyang and Duan, Hongtao and Zhang, Junqi and Sun, Yubo and Jiang, Dongbo and Yan, Xiaolong and Yang, Shuya and Yang, Kun},
  title = {TIMELESS Promotes LUAD Growth via Suppressing Transferrin-Mediated Ferroptosis and Reprograms the Tumor Microenvironment against Anti-PD-1 Immunotherapy},
  journal = {Cancer Communications},
  year = {2026},
  doi = {10.34133/cancomm.0009}
}
Kostenlos starten →